Literature DB >> 20706750

Bone metabolism and the muscle-bone relationship in children, adolescents and young adults with phenylketonuria.

Piotr Adamczyk1, Aurelia Morawiec-Knysak, Paweł Płudowski, Beata Banaszak, Jacek Karpe, Wojciech Pluskiewicz.   

Abstract

The aim of the study was to assess body composition in subjects with phenylketonuria (PKU). Forty-five patients aged 13.8 ± 5.2 years were evaluated. Among them, 15 patients had not reached sexual maturity, showing normal serum values of phenylalanine (Phe) (subgroup 1), and 30 subjects were sexually mature (Tanner 5 stage), showing either normal serum Phe (18 cases; subgroup 2a) or increased serum Phe (12 cases; subgroup 2b). DXA-assessed spine and total body (TB) measurements [bone mineral density (BMD), bone mineral content (BMC), lean body mass (LBM) and the calculated ratios BMC/LBM] as well as laboratory parameters (serum carboxyterminal telopeptide of type I collagen, bone alkaline phosphatase, osteocalcin, parathormone, calcitonin, total and ionized calcium) were analyzed. Statistically significant differences were revealed between subgroup 1 versus 2a for TB BMC/LBM ratio SD scores and between subgroup 2a versus 2b for TB BMD, spine BMD, TB BMC/LBM ratio and spine BMC/LBM ratio SD scores. Stepwise multiple regression analysis revealed that serum Phe negatively affected bone status. The skeletal status in children with PKU is impaired by the disease. Applying body composition parameters instead of BMD alone may reflect the level of impairment in a new, different way.

Entities:  

Mesh:

Year:  2010        PMID: 20706750     DOI: 10.1007/s00774-010-0216-x

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  20 in total

1.  Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.

Authors:  S Yannicelli; D M Medeiros
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

2.  Bone mineral density in patients with phenylketonuria.

Authors:  J Zeman; M Bayer; J Stepán
Journal:  Acta Paediatr       Date:  1999-12       Impact factor: 2.299

3.  Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship.

Authors:  P Płudowski; M Lebiedowski; M Olszaniecka; J Marowska; H Matusik; R S Lorenc
Journal:  Osteoporos Int       Date:  2006-09-02       Impact factor: 4.507

4.  Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age.

Authors:  J L Ferretti; R F Capozza; G R Cointry; S L García; H Plotkin; M L Alvarez Filgueira; J R Zanchetta
Journal:  Bone       Date:  1998-06       Impact factor: 4.398

5.  New approach to osteopenia in phenylketonuric patients.

Authors:  B Pérez-Dueñas; F J Cambra; M A Vilaseca; N Lambruschini; J Campistol; J A Camacho
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

6.  Decreased bone mineralization in children with phenylketonuria under treatment.

Authors:  L Hillman; C Schlotzhauer; D Lee; J Grasela; S Witter; S Allen; R Hillman
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

7.  Importance of lean mass in the interpretation of total body densitometry in children and adolescents.

Authors:  W Högler; J Briody; H J Woodhead; A Chan; C T Cowell
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

8.  Bone mineral status in children with phenylketonuria under treatment.

Authors:  A Al-Qadreh; K H Schulpis; H Athanasopoulou; C Mengreli; A Skarpalezou; I Voskaki
Journal:  Acta Paediatr       Date:  1998-11       Impact factor: 2.299

9.  The relationship between lean body mass and bone mineral content in paediatric health and disease.

Authors:  N J Crabtree; M S Kibirige; J N Fordham; L M Banks; F Muntoni; D Chinn; C M Boivin; N J Shaw
Journal:  Bone       Date:  2004-10       Impact factor: 4.398

10.  Reference values for the indicators of skeletal and muscular status of healthy Polish children.

Authors:  Paweł Płudowski; Halina Matusik; Marzena Olszaniecka; Michał Lebiedowski; Roman S Lorenc
Journal:  J Clin Densitom       Date:  2005       Impact factor: 2.963

View more
  14 in total

1.  Accuracy of six anthropometric skinfold formulas versus air displacement plethysmography for estimating percent body fat in female adolescents with phenylketonuria.

Authors:  Teresa D Douglas; Mary J Kennedy; Meghan E Quirk; Sarah H Yi; Rani H Singh
Journal:  JIMD Rep       Date:  2012-12-29

2.  Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria.

Authors:  Oriane Leuret; Magalie Barth; Alice Kuster; Didier Eyer; Loïc de Parscau; Sylvie Odent; Brigitte Gilbert-Dussardier; François Feillet; François Labarthe
Journal:  J Inherit Metab Dis       Date:  2012-03-03       Impact factor: 4.982

3.  Analysis of the functional muscle-bone unit of the forearm in patients with phenylketonuria by peripheral quantitative computed tomography.

Authors:  Daniela Choukair; Carolin Kneppo; Reinhard Feneberg; Eckhard Schönau; Martin Lindner; Stefan Kölker; Georg F Hoffmann; Burkhard Tönshoff
Journal:  J Inherit Metab Dis       Date:  2016-11-22       Impact factor: 4.982

4.  A New View of Bone Loss in Phenylketonuria.

Authors:  Steven F Dobrowolski; Irina L Tourkova; Cayla R Sudano; Quitterie C Larrouture; Harry C Blair
Journal:  Organogenesis       Date:  2021-08-25       Impact factor: 2.316

5.  Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study.

Authors:  Chiara Montanari; Camilla Ceccarani; Antonio Corsello; Juri Zuvadelli; Emerenziana Ottaviano; Michele Dei Cas; Giuseppe Banderali; Gianvincenzo Zuccotti; Elisa Borghi; Elvira Verduci
Journal:  Nutrients       Date:  2022-04-29       Impact factor: 6.706

Review 6.  A systematic review of bone mineral density and fractures in phenylketonuria.

Authors:  Karen E Hansen; Denise Ney
Journal:  J Inherit Metab Dis       Date:  2014-07-09       Impact factor: 4.982

Review 7.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

8.  Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia.

Authors:  Artemis Doulgeraki; Astrinia Skarpalezou; Areti Theodosiadou; Ioannis Monopolis; Kleopatra Schulpis
Journal:  Int J Endocrinol Metab       Date:  2014-07-01

Review 9.  Bone health in phenylketonuria: a systematic review and meta-analysis.

Authors:  Serwet Demirdas; Katie E Coakley; Peter H Bisschop; Carla E M Hollak; Annet M Bosch; Rani H Singh
Journal:  Orphanet J Rare Dis       Date:  2015-02-15       Impact factor: 4.123

10.  A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.

Authors:  Anne Daly; Wolfgang Högler; Nicola Crabtree; Nick Shaw; Sharon Evans; Alex Pinto; Richard Jackson; Catherine Ashmore; Júlio C Rocha; Boyd J Strauss; Gisela Wilcox; William D Fraser; Jonathan C Y Tang; Anita MacDonald
Journal:  Nutrients       Date:  2021-06-17       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.